Science
The race to make COVID antibody therapies cheaper and more potent – Nature.com
Injections of antibodies might prevent mild COVID-19 from becoming severe, but the treatments are expensive and difficult to make.
Human antibodies attacking the coronavirus (artist’s impression).Credit: Science Lab/Alamy
When US President Donald Trump was ill with COVID-19, his physicians administered a bevy of medications some proven, others experimental. But there is one that the president has hailed as a cure: a cocktail of coronavirus antibodies produced by Regeneron Pharmaceuticals in Tarrytown, New York.
The ‘curative’ power of this antibody treatment has yet to be proven. Although it has shown promise in small, early…
-
General7 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News24 hours agoBrisbane’s original 1979 electric trains take one last journey
-
General23 hours agoParis opens River Seine for public swimming for first time since 1923
-
General21 hours agoDr Daniel Hunt, Michael Long and Christine Anu celebrated at 50th NAIDOC Week Awards